6986.TWO · HEXUN
Taiwan · RS rating 23 · As of 2026-10-08
| Price | 44.30 TWD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 76 / 42 / 13 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 14 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +36.7% |
| Sales growth Q/Q | +29.4% |
| Distance from 52-week high | +36.7% |
| Market cap (USD) | $71.8M |